Loading...

Grand Brilliance Group Holdings Limited

8372.HK•HKSE
HealthcareMedical - Distribution
$0.12
$-0.01(-4.03%)

Grand Brilliance Group Holdings Limited (8372.HK) Stock Overview

Explore Grand Brilliance Group Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for 8372.HKStats details for 8372.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for 8372.HKAnalyst Recommendations details for 8372.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance services, as well as holds trademarks. It sells its products to various private and public hospitals, private clinics, non-profit organizations, universities, and individual end-users. The company was founded in 1997 and is based in Tsuen Wan, Hong Kong. Grand Brilliance Group Holdings Limited is a subsidiary of B&A Success Limited.

CEO

Ms. Bik-Kwan Wong

Employees

50

Headquarters

The Octagon, Tsuen Wan

Founded

2018

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal

Resources

Market

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.